Former Organon President To Head Schering-Plough Global Medical Affairs
This article was originally published in The Pink Sheet Daily
Executive Summary
Hans Vemer, MD/PhD, will be responsible for developing worldwide scientific knowledge about the clinical and economic benefits of Schering-Plough products, the company says. Schering also announces new executive appointments in Europe.
You may also be interested in...
Akzo Nobel Pharma In For “Rough Ride” In 2004; Firm Will Rely On Partnering, R&D Investment
Despite expected “hit from lower sales” for pharmaceuticals in 2004, Akzo will continue to invest in R&D as “something stable,” company tells analysts. Potential 2004 launches include Organon’s Implanon and Variza, both pending at FDA.
Bristol To Name New R&D Head Shortly
Senior VP-Global Clinical & Pharmaceutical Development Elliott Sigal is acting president of Bristol-Myers Squibb’s research institute following the death of James Palmer.
Aranesp Performance Strong Heading Into "Transition" Time, Amgen Says
The company is talking with oncologists about Aranesp ahead of a switch in Medicare reimbursement in January 2005. U.S. sales for the red blood cell product were up 32% in the third quarter.